Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

NCT06315179 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-24

No results posted yet for this study

Summary

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.

Conditions

  • Inflammatory Bowel Diseases
  • Crohn Disease
  • Ulcerative Colitis
  • Indeterminate Colitis
  • Functional Abdominal Pain Syndrome
  • Functional Bowel Disorder
  • Esophageal Diseases
  • Gastroduodenal Disorder
  • Bowel Dysfunction
  • Gallbladder Diseases
  • Sphincter of Oddi Dysfunction
  • Anorectal Disorder

Interventions

DIAGNOSTIC_TEST

Esophagogastroduodenoscopy (EGD) with biopsy

Esophagogastroduodenoscopy (EGD) is a test procedure to examine the lining of the esophagus, stomach, and first part of the small intestine.

DIAGNOSTIC_TEST

Colonoscopy w/ biopsy

Colonoscopy is a test procedure to examine the lining of the different portions of the large intestine: cecum, colon, rectum, and anal canal.

Sponsors & Collaborators

  • Allen Institute

    collaborator UNKNOWN
  • Seattle Children's Hospital

    lead OTHER

Principal Investigators

  • Betty (Hengqi) Zheng, MD · Seattle Children's Hospital, University of Washington

Eligibility

Min Age
6 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-10
Primary Completion
2028-01-31
Completion
2030-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06315179 on ClinicalTrials.gov